FOXO1 inhibits skeletal muscle growth and protein synthesis by inhibiting the activity of essential anabolic pathways, such as mTORC1, leading to muscle wasting and impaired glucose metabolism in obesity. This evidence concerns the gene FOXO1 and obesity disorder.